Sort
50,496 grants matching “lung cancer”
Molecular biomarkers of airway and lung linking COPD and Lung Cancer
$496,897Avrum E Spira · Boston University Medical Campus · R01 · FY2013 · CA
The Evolution of Sarcoma Drug Sensitivity through Time and Space
$496,897Alice Soragni · University Of California Los Angeles · R01 · FY2021 · CA
Novel DNA damage response therapeutics targeting replication protein A
$496,895John J Turchi · Indiana University Indianapolis · R01 · FY2022 · CA
Therapeutic strategies for specific subsets of KRAS mutant lung cancers
$496,876Kwok Kin Wong · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Maladaptive epigenetic control of MUC5B transcription in pulmonary fibrosis
$496,821Anthony N Gerber · University Of Colorado Denver · P01 · FY2025 · HL
Inhibition of P13k and MEK Pathways in the Treatment of Lung Cancer
$496,752Kwok Kin Wong · Dana-Farber Cancer Inst · R01 · FY2011 · CA
Development and application of non-thermal high frequency IRE to treat hepatic tumors
$496,695Rafael Vidal Davalos · Virginia Polytechnic Inst And St Univ · R01 · FY2022 · CA
Radiation Therapy Oncology Group
$496,686Walter John Curran · American College Of Radiology · U10 · FY2010 · CA
Harvard Education Program in Cancer Prevention Control (R25T)
$496,653Glorian C Sorensen · Harvard School Of Public Health · R25 · FY2007 · CA
Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening
$496,598Lisa Carter-Bawa · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Nanotechnologies for Comprehensive Single Cancer Cell Analysis
$496,597Stephen R Quake · Stanford University · U54 · FY2014 · CA
Extracellular Vesicles in Small Cell Lung Cancer Early Detection
$496,494Serge P Nana-Sinkam · Virginia Commonwealth University · U01 · FY2021 · CA
Extracellular Matrix in the Innate Response in Lung Inflammation
$496,492Thomas N Wight · Benaroya Research Inst At Virginia Mason · P01 · FY2011 · HL
Discovery of small molecule inhibitors for protein N-terminal acetyltransferase D
$496,475Rong Huang · Purdue University · R01 · FY2024 · CA
Inhibition of P13k and MEK Pathways in the Treatment of Lung Cancer
$496,412Kwok Kin Wong · Dana-Farber Cancer Inst · R01 · FY2012 · CA
PHASE II/III CLINICAL TRIALS OF ANTICANCER AGENTS
$496,374University Of Texas Md Anderson Can Ctr · U01 · FY2000 · CA
Occupational Exposure Assessment
$496,359Melissa Friesen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
NIMHD Adjunct Investigator Program
$496,333Kelvin Choi · National Institute On Minority Health And Health Disparities · ZIJ · FY2023 · MD
Communicating Waterpipe Tobacco Harms to Reduce Use among Young Adults
$496,329Erin L Sutfin · Wake Forest University Health Sciences · R01 · FY2022 · CA
Protein interactions regulate iron storage and utilization in bacteria
$496,314Mario Rivera · Louisiana State University · · FY2017 · BIO
The Epidemiology of Molecular Alterations in Mesothelioma
$496,312Karl T Kelsey · Brown University · R01 · FY2008 · CA
Project 2: Inhibiting AXL to Improve Treatment Response in Endometrial Cancer
$496,247David G Mutch · Washington University · P50 · FY2025 · CA
Reasons for Racial Disparities in Venous Thromboembolism
$496,163Neil Adrian Zakai · University Of Vermont & St Agric College · RC1 · FY2010 · HL
SAN JUAN MB COMMUNITY CLINICAL ONCOLOGY PROGRAM
$496,129San Juan City Hospital · U10 · FY2004 · CA
Training in Comparative Lung Biology and Medicine
$496,128Nicholas J Kenyon · University Of California At Davis · T32 · FY2021 · HL